本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Salarius Pharmaceuticals Inc

0.7561
-0.0339-4.29%
盘后0.7099-0.0462-6.11%19:56 EDT
成交量:108.41万
成交额:92.06万
市值:160.84万
市盈率:-0.17
高:0.8898
开:0.8590
低:0.6570
收:0.7900
数据加载中...
2020/03/11

重要事件披露

Current report, item 8.01
2020/02/21

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/21

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/18

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 3.03, 5.03, 7.01, 8.01, and 9.01
2020/02/06

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/29

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/28

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/10

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/28

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2019/10/22

重要事件披露

Current report, item 5.07
2019/09/18

重要事件披露

[Amend] Current report, items 8.01 and 9.01
2019/09/16

重要事件披露

Current report, items 5.02, 8.01, and 9.01